Oncotarget Experimental Triple Therapy Improves Survival in Glioblastoma Mouse Model There are more than 13,000 new cases of malignant brain tumors diagnosed each year... read more June 4, 2025
Oncotarget Engineered Proteins Show Promise in Stopping Glioblastoma Invasion The results demonstrated that the minimal TIMP variants, mTC1, and mTC3, effectively inhibit MMP activity... read more May 21, 2025
Oncotarget Panitumumab and Low-Dose Capecitabine: A Promising Maintenance Therapy for Metastatic Colorectal Cancer Considerations around maintenance therapy are of particular importance when drugs associated with cumulative neurotoxicity like... read more May 7, 2025
Oncotarget New Insights into p53: A Powerful Gene’s Role in Cancer Therapy studies that employ TP53-wild type cancer cells and their isogenic derivatives may systematically fail to... read more April 22, 2025
Oncotarget How a Simple Blood Test Could Predict Colorectal Cancer Surgery Success The concentration of cell-free DNA (cfDNA) before and after surgery may be related to the... read more February 26, 2025
Oncotarget A New Approach for Cancer Treatment: The Surprising Relationship Between KLRG1 and PD-1 The anti-correlation of PD-1 and KLRG1 expression in human tumor infiltrating CD8 T cells suggests... read more January 28, 2025
Oncotarget Mastocytosis: Key Insights into KIT M541L Gene Mutation To our knowledge, this is the first case/control study to show a significant genetic... read more January 15, 2025
Oncotarget Cancer Dormancy and Tumor Recurrence: New Insights for Breast Cancer Cancer dormancy, followed by recurrence remains a poorly understood phenomenon in both cancer biology and... read more November 13, 2024
Oncotarget Next-Generation Antibodies for Cancer Therapy This study focuses on developing a new generation of antibodies that can get inside cancer... read more October 24, 2024
Oncotarget Targeting Stem Cell-like Traits: How miR-10b Inhibition Treats Metastatic Breast Cancer Our results demonstrate that inhibition of miR-10b using MN-anti-miR10b decreases the stemness of breast cancer... read more October 11, 2024